The rise of Sildenafil initially drove a period of growth for the drug industry, but recent changes present a murky picture for investors. Off-patent versions are eating into revenue, and persistent patent challenges https://orlandotebg207469.tokka-blog.com/41606478/sildenafil-and-the-pharmaceutical-industry-a-risky-bet